A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year Released2026-01-09 12:05 health newsnewsweb article Read more on www.cnbc.com A Picture from image.cnbcfm.com Related items Published byCCNBC In one list NewsNews330,529 items